文献速递结核与非结核分枝杆菌艾滋病与性传播感染

美国出生HIV感染者潜伏结核感染检测策略优化

Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV).
PubMed 文献 · Clin Infect Dis · 2021-01-01

本研究采用贝叶斯潜类别分析,在美国出生HIV感染者中估计潜伏结核感染(LTBI)患病率为4.7%,并比较TST、QFT和TSPOT的诊断性能。TSPOT特异性(99.7%)和阳性预测值(90.0%)显著高于QFT和TST,而QFT敏感性(72.2%)最高,所有检测阴性预测值均较高。

要点

  • 美国出生HIV感染者LTBI患病率低(4.7%)。
  • TSPOT阳性预测值最高(90.0%),优于QFT和TST。
  • QFT敏感性最高(72.2%),但特异性较低。

核心结论

  • 在美国出生HIV感染者中,LTBI患病率较低,TSPOT因高阳性预测值可能更适用于低结核暴露风险且CD4+计数高的美国出生HIV感染者。

研究设计与样本

  • 前瞻性多中心队列研究,纳入1510名美国出生≥5岁HIV感染者,所有对象三种LTBI检测均有有效结果,采用贝叶斯潜类别分析估计LTBI患病率和检测特征。

主要发现

  • 估计LTBI患病率为4.7%,中位CD4+计数为532 cells/mm3。
  • TSPOT特异性为99.7%,显著高于QFT(96.5%)和TST(96.8%);TSPOT阳性预测值为90.0%,显著高于QFT(50.7%)和TST(45.4%)。
  • QFT敏感性为72.2%,显著高于TST(54.2%)和TSPOT(51.9%);所有检测阴性预测值均高(TST 97.7%,QFT 98.6%,TSPOT 97.6%)。
  • 即使在最高评估cutoff(TST 15 mm,QFT ≥1.00 IU/mL,TSPOT ≥8 spots)下,TST和QFT特异性仍显著低于TSPOT。

关键数值与推荐

  • 标准美国cutoff:TST ≥5 mm,QFT ≥0.35 IU/mL,TSPOT ≥8 spots。
  • 最高评估cutoff:TST 15 mm,QFT ≥1.00 IU/mL,TSPOT ≥8 spots。

临床怎么用

  • 对于美国出生、结核暴露风险低且CD4+计数高的HIV感染者,TSPOT因高阳性预测值可能更优。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increased risk of progression from latent tuberculosis infection (LTBI) to tuberculosis (TB) disease among people living with human immunodeficiency virus (HIV; PLWH) prioritizes them for LTBI testing and treatment. Studies comparing the performance of interferon gamma release assays (IGRAs) and the tuberculin skin test (TST) among PLWH are lacking. METHODS: We used Bayesian latent class analysis to estimate the prevalence of LTBI and diagnostic characteristics of the TST, QuantiFERON Gold In-Tube (QFT), and T.SPOT-TB (TSPOT) among a prospective, multicenter cohort of US-born PLWH ≥5 years old with valid results for all 3 LTBI tests using standard US cutoffs (≥5 mm TST, ≥0.35 IU/mL QFT, ≥8 spots TSPOT). We also explored the performance of varying LTBI test cutoffs. RESULTS: Among 1510 PLWH (median CD4+ count 532 cells/mm3), estimated LTBI prevalence was 4.7%. TSPOT was significantly more specific (99.7%) and had a significantly higher positive predictive value (90.0%, PPV) than QFT (96.5% specificity, 50.7% PPV) and TST (96.8% specificity, 45.4% PPV). QFT was significantly more sensitive (72.2%) than TST (54.2%) and TSPOT (51.9%); negative predictive value of all tests was high (TST 97.7%, QFT 98.6%, TSPOT 97.6%). Even at the highest cutoffs evaluated (15 mm TST, ≥1.00 IU/mL QFT, ≥8 spots TSPOT), TST and QFT specificity was significantly lower than TSPOT. CONCLUSIONS: LTBI prevalence among this cohort of US-born PLWH was low compared to non-US born persons. TSPOT's higher PPV may make it preferable for testing US-born PLWH at low risk for TB exposure and with high CD4+ counts.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Pettit AC, Stout JE, Belknap R, et al. Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2021. PMID: 32761083. doi:10.1093/cid/ciaa1135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。